The role of wheezing subtypes in the development of early childhood asthma

Donald E Warden1, Hongmei Zhang2, Yu Jiang2

  • 1Division of Epidemiology, Biostatistics and Environmental Health, School of Public Health, University of Memphis, Memphis, TN, 38152-0001, USA. dewarden@memphis.edu.

Respiratory Research
|February 28, 2025
PubMed

Insights

Identifying specific early childhood wheezing patterns, not just wheezing occurrence, can predict asthma risk. Certain wheeze trajectories, like progressive non-infectious wheeze, are linked to higher asthma development.

Area of Science:

  • Pediatric respiratory health
  • Asthma epidemiology
  • Developmental pediatrics

Background:

  • Early childhood wheezing is a known risk factor for later-life asthma.
  • Understanding wheezing patterns is crucial for predicting asthma development.

Purpose of the Study:

  • To identify distinct wheezing trajectories in early childhood.
  • To examine the association of these trajectories with asthma and lung function later in life.

Main Methods:

  • Utilized group-based trajectory models on data from the Isle of Wight Birth Cohort (IOWBC) F2-generation (n=603).
  • Tracked wheeze prevalence and type (general, infectious, non-infectious) from 3 to 72 months.
  • Analyzed associations between identified wheeze trajectories (ages 3-36 months) and asthma/lung function at 6 years.

Main Results:

  • Identified distinct trajectories for general, infectious, and non-infectious wheezing.
  • Four trajectories were associated with increased asthma risk: 'Progressive' non-infectious, 'Early Occurrence' non-infectious, 'Persistent' infectious, and 'Persistent' general wheeze.
  • The 'Infrequent/Never' wheeze trajectory served as the reference group.

Conclusions:

  • Wheeze trajectories, categorized by etiology, are significant risk factors for asthma.
  • Early identification of specific wheeze patterns, beyond mere occurrence, can inform clinical interventions.
  • Findings highlight the complex, multifactorial nature of asthma onset and potential for early risk mitigation.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
324
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.4K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
222